HeberFERON, a unique Cuban medicine
The extension of therapeutic coverage to all municipalities across the country, with the opening of more sites, is the key strategy in the application program for HeberFERON; a one-of-a-kind medicine to treat skin cancer (basal cell carcinoma), developed and produced by Cuba’s Center for Genetic Engineering and Biotechnology (CIGB).